LTK 25mg Tablet contains Losartan 25mg, an angiotensin II receptor antagonist primarily used in the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Losartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, including stroke, myocardial infarction, and renal impairment. LTK 25mg is indicated for the treatment of essential hypertension and may be prescribed to reduce the risk of stroke in patients with left ventricular hypertrophy. Additionally, it is beneficial in managing diabetic nephropathy in patients with type 2 diabetes and proteinuria. The tablet is administered orally, typically once daily, with or without food, as directed by a healthcare professional. Dosage adjustments may be necessary based on patient response and renal function. Common adverse effects include dizziness, headache, and fatigue, while serious side effects are rare but may involve hyperkalemia or renal impairment. LTK 25mg should be used cautiously in patients with hepatic or renal dysfunction and is contraindicated during pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended to ensure safety and efficacy during treatment.